Biotin-LEED-FMK features a LEED motif, FMK electrophile, and biotin tag for affinity-based detection. The peptide aids in identifying proteases recognizing acidic-rich sequences. Researchers use it to study covalent inhibition, substrate mapping, and enzyme enrichment. Its multifunctional design enhances assay versatility.
CAT No: HB00044
Biotin-LEED-FMK is a specialized biochemical probe that combines a biotinylated peptide sequence with a fluoromethyl ketone (FMK) functional group, designed for targeted inhibition and detection of specific protease activities. As a synthetic peptide derivative, it incorporates the LEED tetrapeptide motif, which is recognized by certain proteases, and an FMK moiety that covalently modifies active site cysteines, rendering the enzyme inactive. The biotin label enables subsequent affinity-based detection or purification, making this compound a valuable tool in protease research and related biochemical studies. Its unique structure allows for selective interaction with target enzymes, facilitating both mechanistic investigations and methodological advancements in enzymology.
Protease activity profiling: Biotin-LEED-FMK is widely employed in the characterization and profiling of cysteine proteases, particularly those that recognize the LEED peptide motif. By acting as an irreversible inhibitor, it binds covalently to the active site of target enzymes, enabling researchers to distinguish active protease populations within complex biological samples. The biotin tag allows for sensitive detection and quantification of labeled proteases via streptavidin-based assays, supporting studies into protease expression, regulation, and function across diverse biological systems.
Enzyme mechanism studies: The FMK warhead in this compound provides a powerful means to investigate catalytic mechanisms of cysteine proteases. By forming a stable covalent adduct with the catalytic cysteine residue, the inhibitor effectively "traps" the enzyme in a defined state. This property facilitates structural and kinetic analyses, allowing scientists to dissect the molecular details of substrate recognition, catalysis, and inhibitor binding. Such insights are essential for understanding enzyme specificity and for informing the rational design of future inhibitors.
Affinity purification of active enzymes: The biotinylated nature of the molecule enables its use in affinity-based enrichment protocols. Following incubation with biological samples, proteases that interact with the inhibitor can be selectively captured using streptavidin-coated matrices. This approach allows for the isolation and subsequent identification or characterization of active protease species from complex mixtures, supporting proteomic workflows and biomarker discovery initiatives.
Inhibitor screening and validation: As a structurally defined, mechanism-based inhibitor, Biotin-LEED-FMK serves as a reference compound for evaluating the potency and selectivity of novel protease inhibitors. Researchers can utilize it in competitive binding assays to benchmark new compounds, assess off-target effects, or validate the specificity of candidate molecules. This application is particularly valuable in early-phase drug discovery and functional screening campaigns where precise enzyme targeting is critical.
Cellular localization studies: The biotin tag incorporated into the inhibitor facilitates visualization of protease distribution within cells and tissues. Using labeled streptavidin conjugates, scientists can track the subcellular localization of active protease-inhibitor complexes through microscopy or flow cytometry techniques. This capability provides spatial context to protease activity, enabling studies of enzyme compartmentalization, trafficking, and dynamics in physiological and experimental settings.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More